[Skip to Content]
[Skip to Content Landing]
July 5, 1965

Amphetamine Reevaluation Urged

JAMA. 1965;193(1):A45-A50. doi:10.1001/jama.1965.03090010105049

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The clinical value of amphetamine-type drugs should be reassessed in view of the steady accumulation of evidence that these drugs are not as safe as they were once thought to be, a British physician told the AMA Convention.

In the last five years a number of reports have been published giving details of cases of habituation or addiction to these drugs, said Philip H. Connell, MD, the Bethlem Royal and the Maudsley Hospital, London.

"It seems clear, therefore, that these drugs, which are prescribed so widely, are not as safe as had been previously suggested, and that a new look into their real value in clinical medicine is needed in order that the prescribing of these drugs can be evaluated in relation to their dangers," Connell said.

"The responsibility of the family doctor is a very real one," he added, "and it is a pity that there have been so

First Page Preview View Large
First page PDF preview
First page PDF preview